Evinco Therapeutics and ARMI announce research collaboration to advance a novel NK-EV therapy for Alzheimer’s disease

Collaboration will generate human iPSC-derived brain cell models to investigate the effects of Evinco’s NK-EV platform on neuroinflammation Melbourne